News Archive

Presentations

05/30/2025

The Translational Breast Cancer Research Consortium was well represented at the 2025 ASCO Meeting. Click here for links to the abstracts.

12/10/2024

The Translational Breast Cancer Research Consortium was well represented at the 2024 San Antonio Breast Cancer Symposium (SABCS).  Click here for a summary of the trials presented.

12/10/2024

The Translational Breast Cancer Research Consortium was well represented at the 2024 San Antonio Breast Cancer Symposium (SABCS).  Click here for a summary of the trials presented.

07/01/2024

The Translational Breast Cancer Research Consortium was well represented at the 2024 ASCO Meeting. Click here for links to the abstracts.

3/23/2024

TBCRC 034 will be presented at the SSO 2024 Annual Meeting.

12/5/2023

The Translational Breast Cancer Research Consortium was well represented at the 2023 San Antonio Breast Cancer Symposium (SABCS). Click here for a summary of the trials presented.

10/20/2023

TBCRC 026 will be presented at the 2023 ESMO Congress.

12/6/2022

The Translational Breast Cancer Research Consortium was well represented at the 2022 San Antonio Breast Cancer Symposium. Click here for a summary of the trials presented.

9/9/2022

TBCRC 026 was presented at the 2022 ESMO Congress.

9/7/2022

The Aurora Retrospective Trial was presented at the 2022 Metastatic Breast Cancer Research Conference.

6/3/2022

The Translational Breast Cancer Research Consortium had two meetings at the 2022 ASCO Meeting.  Click here for links to the abstracts.

4/8/2022

The Aurora Retrospective Trial was presented at the 2022 American Association for Cancer Research (AACR) Annual Meeting.

12/7/2021

The Translational Breast Cancer Research Consortium was well represented at the 2021 San Antonio Breast Cancer Symposium.  Click here for a summary of the trials presented.

10/26/2021

The local therapy outcomes and toxicity from TBCRC 033 will be presented at the 2021 American Society for Radiation Oncology (ASTRO).

10/24/2021

TBCRC 033 was presented at the 2021 American Society for Radiation Oncology (ASTRO) Annual Meeting.

6/4/2021

The Translational Breast Cancer Research Consortium was well represented at the 2021 ASCO Meeting. Click here for links to the abstracts.

12/9/2020

The Translational Breast Cancer Research Consortium was well represented at the 2020 San Antonio Breast Cancer Symposium. Click here for links to the abstracts.

11/19/2020

TBCRC 049 was presented at the 2020 Society for NeuroOncology Virtual Meeting.

5/29/2020

The Translational Breast Cancer Research Consortium was well represented at the 2020 ASCO Meeting. Click here for links to the abstracts.

5/29/2020

The Translational Breast Cancer Research Consortium was well represented at the 2020 ASCO Meeting. Click here for links to the abstracts.

12/10/2019

The Translational Breast Cancer Research Consortium was well represented at the 2019 San Antonio Breast Cancer Symposium. Click here for links to the abstracts.

3/29/2019

The results of TBCRC 035 were presented at the 2019 American Association of Cancer Research (AACR) Annual Meeting.

3/27/2019

The results of TBCRC 034 were presented at the 2019 Society of Surgical Oncology (SSO) Annual Cancer Symposium.

12/4/2018

The Translational Breast Cancer Research Consortium was well represented at the 2018 San Antonio Breast Cancer Symposium. Click here for links to the abstracts

9/13/2018

An imaging prognostic biomarker from TBCRC 026 was presented at the 2018 World Molecular Imaging Congress

6/1/2018

The Translational Breast Cancer Research Consortium was well represented at the 2018 ASCO Meeting. Click here for links to the abstracts

12/5/2017

The Translational Breast Cancer Research Consortium was well represented at the 2017 San Antonio Breast Cancer Symposium. Click here for links to the abstracts

6/2/2017

The Translational Breast Cancer Research Consortium had two meetings at the 2017 American Society of Clinical Oncology (ASCO) Meeting. Click here for links to the meetings.

12/6/2016

The correlative results of TBCRC 008 were presented at the 2016 San Antonio Breast Cancer Symposium. Click here for links to the abstracts.

4/13/2016

The registry results of TBCRC 013 were presented at the 2016 American Society of Breast Surgeons Annual Meeting.

12/8/2015

The Translational Breast Cancer Research Consortium had several meetings at the 2015 San Antonio Breast Cancer Symposium. Click here for links to the meetings.

5/29/2015

The Translational Breast Cancer Research Consortium was well represented at the 2015 American Society of Clinical Oncology (ASCO) Meeting. Click here for links to the meetings.

3/25/2015

The results of TBCRC 020 were presented at the 2015 Society of Surgical Oncology Annual Cancer Symposium.

12/9/2014

The Translational Breast Cancer Research Consortium had several meetings at the 2014 San Antonio Breast Cancer Symposium. Click here for links to the meetings.

5/30/2014

The Translational Breast Cancer Research Consortium was well represented at the 2014 American Society of Clinical Oncology (ASCO) Click here for links to the presentations.

12/10/2013

The Translational Breast Cancer Research Consortium had several presentations at the 2013 San Antonio Breast Cancer Symposium. Click here for links to the presentations.

05/31/2013

The Translational Breast Cancer Research Consortium was well represented at the 2013 American Society of Clinical Oncology (ASCO) Meeting. Click here for links to the presentations.

Publications

04/09/2025

More correlative analyses from TBCRC 026 were published in JCO Precis Oncology.

03/13/2025

Additional results from TBCRC 057 were published in JCO Oncology Practice.

03/01/2025

Correlative analyses from TBCRC 026 were published in Breast.

09/02/2024

Additional results from TBCRC 038 (analysis by self-reported race) were published in Breast Cancer Research.

6/27/2024

The 5-Year Results and Correlative Analyses from TBCRC 033 was published in the Journal of Clinical Oncology

04/24/2024

Additional correlative work from TBCRC 043 was published in Cancer Research Communications.

3/11/2024

The results from TBCRC 057 were published in Cancer Medicine.

2/8/2024

A correlative analysis from TBCRC 043 was published in Cancer Discovery.

2/1/2024

The clinical results of TBCRC 043 were published in JAMA Oncology.

1/31/2024

The results from TBCRC 039 were published in Breast Cancer Research.

10/3/2023

The quality of life analysis from TBCRC 029 was published in Oncologist.

10/1/2023

Additional clinical work from TBCRC 030 was published in Annals of Oncology.

8/31/2023

The results from TBCRC 026 were published in the Journal of Nuclear Medicine.

8/17/2023

Correlative analyses using samples from TBCRC 008 and 030 were published in Breast Cancer Research and Treatment.

6/1/2023

The results from TBCRC 041 were published in JAMA Oncology

5/17/2023

Correlative results from TBCRC 023 were published in Clinical Cancer Research

5/1/2023

Correlative results from TBCRC 030 were published in Nature Genetics

1/4/2023

The results from the Aurora Retrospective study were published in Nature Cancer

12/12/2022

An analysis of TBCRC 038 was published in Cancer Cell

5/1/2022

Local therapy outcomes and toxicity from TBCRC 033 were published in International Journal of Radiation Oncology, Biology, Physics

2/16/2022

Cardiac outcome results from TBCRC 033 were published in NPJ Breast Cancer

7/20/2021

The results from TBCRC 033 were published in the Journal of Clinical Oncology.

5/12/2021

The results from TBCRC 036 were published in NPJ Breast Cancer.

12/20/2020

The results from TBCRC 048 were published in the Journal of Clinical Oncology.

10/12/2020

The results from TBCRC 034 were published in the Annals of Surgical Oncology.

8/13/2020

The results from TBCRC 030 were published in the Annals of Oncology.

6/1/2020

The results from TBCRC 015 were published in Breast Cancer Research and Treatment.

5/10/2020

The results from TBCRC 031 were published in the Journal of Clinical Oncology.

5/1/2020

The results from TBCRC 032 were published in Clinical Cancer Research.

4/1/2020

Additional results from TBCRC 022 were published in Clinical Breast Cancer.

2/18/2020

The results from TBCRC 002 were published in Breast Cancer Research.

2/15/2020

The results from TBCRC 023 were published in Clinical Cancer Research.

1/1/2020

Correlative results from TBCRC 023 were published in Journal of the National Cancer Institute.

6/1/2019

The results from TBCRC 006 and 023 were published in Annals of Oncology.

5/13/2019

The results from TBCRC 030 were presented at the 2019 American Society of Clinical Oncology Annual Meeting.

5/1/2019

The results from the additional cohorts of TBCRC 022 were published in the Journal of Clinical Oncology.

3/20/2019

The results of TBCRC 026 were published in the Journal of Clinical Oncology.

10/23/2018

A biomarker analysis of TBCRC 024 was presented at the 2018 American Society for Radiation Oncology Annual Meeting

10/12/2018

The results from TBCRC 027 were published in NPJ Breast Cancer.

5/1/2018

The results from TBCRC 024 were published in the Journal of Clinical Oncology.

2/1/2018

A retrospective characterization of male breast cancer was published in the Annals of Oncology.

2/1/2018

TBCRC 006 correlative study results were published in Breast Cancer Research and Treatment.

01/01/2018

TBCRC 008 correlative study results were published in Breast Cancer Research and Treatment.

9/1/2017

A pathologic characterization of male breast cancer, through retrospective tissue collection, was published in the European Journal of Cancer.

3/1/2017

The TBCRC 005 prospective biomarker study results were published in the Journal of Clinical Oncology.

12/1/2016

The results of TBCRC 010 were published in Clinical Cancer Research.

7/10/2016

The TBCRC 013 results were published in the Journal of Clinical Oncology.

6/3/2016

The results of TBCRC 013 were presented at the 2016 American Society of Clinical Oncology (ASCO) Meeting.

5/20/2016

The TBCRC 015 results were published in Oncotarget.

3/23/2016

The TBCRC 020 results were published in the Annals of Surgical Oncology.

3/20/2016

The TBCRC 022 results from one arm of the trial were published in the Journal of Clinical Oncology.

4/6/2015

The TBCRC 009 results were published in the Journal of Clinical Oncology.

3/6/2015

The TBCRC 019 clinical trial results and the circulating tumor cell analyses were published in Clinical Cancer Research.

1/1/2015

Additional results from TBCRC 017 were published in the Annals of Surgical Oncology.

12/18/2014

The results of the TBCRC 001 circulating tumor cell analysis were published in Clinical Cancer Research.

12/4/2014

The TBCRC 008 results were published in the Journal of Nuclear Medicine.

9/26/2014

The TBCRC 007 results were published in Breast Cancer Research and Treatment.

7/8/2014

The results from TBCRC 018 were published in Breast Cancer Research and Treatment.

4/15/2014

Results of a novel blood test (using specimens from TBCRC 005 and 013) that monitors treatment response and/or breast recurrence were published in Cancer Research.

10/1/2013

The results from TBCRC 011 were published in Clinical Cancer Research.

5/15/2013

The results from TBCRC 017 were published in Cancer.

5/10/2013

The results from TBCRC 006 were published in the Journal of Clinical Oncology.

Other TBCRC Activities

12/31/2023

A summary of the 2023 TBCRC meetings and publications is available by clicking here.

01/11/2023

Press Release: Aurora US Study Reports New Details on Drivers of Metastasis

12/31/2022

A summary of the 2022 TBCRC meetings and publications is available by clicking here.

12/31/2021

A summary of the 2021 TBCRC meetings and publications is available by clicking here.

12/31/2020

A summary of the 2020 TBCRC meetings and publications is available by clicking here.

12/31/2019

A summary of the 2019 TBCRC meetings and publications is available by clicking here.

12/31/2018

A summary of the 2018 TBCRC meetings and publications is available by clicking here.